Charles Nemeroff | |
|---|---|
 Charles Nemeroff | |
| Born | Charles Barnet Nemeroff September 1949 (age 73) |
| Alma mater | University of North Carolina at Chapel Hill Northeastern University City College of New York |
| Occupation | Psychiatrist |
| Employer | University of Texas at Austin |
Charles Barnet Nemeroff (born 1949) is an American psychiatrist known for his works about depression. He is the author of numerous textbooks, papers, and clinical studies.
Nemeroff was born in New York City and attended the City College of New York. During his freshman year at the college, he visited Manhattan State Hospital where he decided to pursue his career studying mental illness. [1] He also participated in an undergraduate research program sponsored by the National Science Foundation. Nemeroff went to work as a technician in a neuropathology laboratory in Boston after graduating in 1970. He subsequently returned to school where he received a master's degree in Biology in 1973 from Northeastern University. He then earned his PhD in neurobiology in 1973 and his M.D. in 1981, both from the University of North Carolina at Chapel Hill. [1]
Nemeroff joined the faculty of Duke University after completing his training, then took a position at the Emory University School of Medicine in 1991. During his time at Emory, he built the psychiatry department into one of the field's leading centers [2] and became internationally recognized as a leader in psychiatric research. [3]
Nemeroff has drawn criticism for accepting consulting fees from drug companies whose products he has reviewed. [3] [4] In 2008, he resigned from the position of chairman after Emory University found him in violation of policy for not disclosing payments received from drug makers for consulting fees. [5] He was forbade to apply for or be involved with any National Institutes of Health grants for a period of two years. [2] At the time he left the university, he was considered one of the nation's most influential psychiatrists, having written more than 850 research reports and reviews. [4]
In 2009, Nemeroff became the chair of psychiatry at the University of Miami Miller School of Medicine. [6] In 2018, Nemeroff became chair and professor of psychiatry at the University of Texas at Austin Dell Medical School. [7]
Peter G. Bourne is a physician, anthropologist, author and international civil servant with experience in several senior government positions. He is currently a visiting senior research fellow at Green Templeton College, Oxford, vice-chancellor emeritus at St. George's University in Grenada and chair of the Medical Education Cooperation with Cuba (MEDICC). He is also a distinguished fellow of the Rothermere American Institute at the University of Oxford.
Leon Eisenberg was an American child psychiatrist, social psychiatrist and medical educator who "transformed child psychiatry by advocating research into developmental problems".
The Lewis Katz School of Medicine at Temple University (LKSOM), located on the Health Science Campus of Temple University in Philadelphia, PA, is one of 7 schools of medicine in Pennsylvania conferring the M.D. degree. It also confers the Ph.D. and M.S. degrees in biomedical sciences. In addition, LKSOM offers a Narrative Medicine Program.
Pascal J. Goldschmidt-Clermont is a Belgian-American cardiologist and cardiovascular researcher, and former dean of the University of Miami Leonard M. Miller School of Medicine. Until January 2016 he also served as chief executive officer of the University of Miami Health System (UHealth), which includes six hospitals and outpatient facilities in Miami-Dade, Broward, Palm Beach, Monroe and Collier counties.
Frederick King Goodwin was an American psychiatrist and Clinical Professor of Psychiatry at the George Washington University Medical Center, where he was also director of the Center on Neuroscience, Medical Progress, and Society. He was a specialist in bipolar disorder and recurrent depression.
Dennis S. Charney is an American biological psychiatrist and researcher, with expertise in the neurobiology and treatment of mood and anxiety disorders. He is the author of Neurobiology of Mental Illness, The Physician's Guide to Depression and Bipolar Disorders and Molecular Biology for the Clinician, as well as the author of over 600 original papers and chapters. In 2022, he was listed #52 on Research.com's "Top Medicine Scientists in the United States," with an h-index of 194 with 146,109 citations across 651 publications. Charney is known for demonstrating that ketamine is effective for treating depression. Ketamine's use as a rapidly-acting anti-depressant is recognized as a breakthrough treatment in mental illness.
Jeffrey Alan Lieberman is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia. He was president of the American Psychiatric Association from May 2013 to May 2014.
Steven Samuel "Steve" Sharfstein is an American psychiatrist. He was secretary of the American Psychiatric Association from 1991 to 1995, its vice president from 2002 to 2004, and president from 2005 to 2006. Sharfstein also received the Human Rights Award from the American Psychiatric Association in 2007.
Igor Grant is an American psychiatrist. He is Distinguished Professor in the Department of Psychiatry in the School of Medicine at the University of California, San Diego. He is Director of the HIV Neurobehavioral Research Program (HNRP) and the Center for Medicinal Cannabis Research (CMCR). Grant is the founding Editor of the Journal of the International Neuropsychological Society and founding co-editor of the journal AIDS and Behavior. His work focuses on effects of HIV and drug use, particularly alcohol, medical marijuana, and methamphetamine.
Donald Jay Cohen was an American psychiatrist, psychoanalyst, and director of the Yale Child Study Center and the Sterling Professor of Child Psychiatry, Pediatrics and Psychology at the Yale School of Medicine. According to the New York Times, he was "known for his scientific work, including fundamental contributions to the understanding of autism, Tourette's syndrome and other illnesses, and for his leadership in bringing together the biological and the psychological approaches to understanding psychiatric disorders in childhood"; his work "reshaped the field of child psychiatry". He was also known as an advocate for social policy, and for his work to promote the interests of children exposed to violence and trauma.
Charles P. O'Brien is a research scientist, medical educator and a leading expert in the science and treatment of addiction. He is board certified in neurology, psychiatry and addiction psychiatry. He is currently the Kenneth E. Appel Professor of Psychiatry, and vice chair of psychiatry, in the Perelman School of Medicine at the University of Pennsylvania.
Edward Thomas Bullmore, is a British neuropsychiatrist, neuroscientist and academic. Since 1999, he has been Professor of Psychiatry at the University of Cambridge. In 2005, he also became Vice-President of Experimental Medicine at GlaxoSmithKline while maintaining his post at University of Cambridge.
Augustus John Rush is an internationally renowned psychiatrist. He is a professor emeritus in Duke-NUS Medical School at the National University of Singapore (NUS), and adjunct professor of psychiatry and behavioral sciences at Duke University School of Medicine. He has authored and edited more than 10 books, and over 600 scientific journal articles that are largely focused on the diagnosis and treatment of depressive and bipolar disorders.
Elisabeth Binder is a medical doctor and neuroscientist specializing in the study of mood and anxiety disorders. She is the director of the Department of Translational Research of the Max Planck Institute of Psychiatry in Munich, Germany. In addition to research, she is a member of the executive committee of the European College of Neuropsychopharmacology (ECNP).
Charles L. Raison is an American psychiatrist and professor of psychiatry at the University of Wisconsin-Madison School of Medicine and Public Health as well as the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor with the School of Human Ecology in Madison, Wisconsin.
Dan Markingson was a young man from St. Paul, Minnesota who committed suicide in an ethically controversial psychiatric research study at the University of Minnesota while under an involuntary commitment order. For nearly eleven years, University of Minnesota officials defended the conduct of its researchers, despite significant public criticism, numerous news reports, and pressure for an external investigation. In March 2015, however, an investigation by a state watchdog agency found a number of alarming ethical violations in the case, including serious conflicts of interest and financial incentives, poor oversight of the study, pressure on Markingson to join the study while he was in a highly vulnerable state, and a series of misleading public statements by university officials. Shortly afterward, the university suspended recruitment into psychiatric research studies. On April 9, 2015, Charles Schulz, MD, announced his resignation as Chair of the Department of Psychiatry.
Lewis Lund Judd was an American neurobiologist and psychiatrist. He served as director of the National Institute of Mental Health (NIMH) from 1988 to 1992, chair of the Department of Psychiatry at the University of California, San Diego from 1977 to 2013, and as a vice president of the American Psychiatric Association. As NIMH director he helped develop the "Decade of the Brain", a research plan designed "to bring a precise and detailed understanding of all the elements of brain function within our own lifetime."
Peter Elliott is a British pharmacologist and drug developer who has initiated clinical trials across a range of disease areas, and is the co-developer of Velcade, a drug used to treat multiple myeloma.
Christopher J. Pittenger is an American psychiatrist and translational neuroscientist. He is a professor of psychiatry at the Yale School of Medicine and Director of the Yale OCD Research Clinic.
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
